Recent Research Reveals the Impact of Drug Rebates on Formulary Design in Medicare Part D module
HSI faculty researcher and Wharton Professor study the Impact of Drug Rebates on Formulary Design in Medicare Part D module
HSI faculty researcher and Wharton Professor study the Impact of Drug Rebates on Formulary Design in Medicare Part D module
By
Since the 2016 U.S. Presidential election and British “Brexit” referendum — and then COVID-19 — opened the floodgates on fake news, research has delved into the psychology behind online misinformation
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
Got a bad case of platform envy? Find out why “seeding” and “coring” matter, and be open to a better way.
By
A new study finds credit agency ratings don’t reflect the risk profile of collateralized loan obligations, a challenge for investors and policymakers alike.
This page highlights the case studies, policy work and policy simulation of the Climate Policy Center
By
A recent study by MIT Sloan School of Management Prof. Nemit Shroff found that firms with common owners are more likely to disclose information.
In October 2024, the Legatum Center for Development Entrepreneurship at MIT conducted a two-day workshop titled "Hedging Currency Risk: Innovative Lending Strategies for SMEs in Africa." The workshop brought together a diverse group of entrepreneurs, investors, economists, and thought leaders to tac...
By
Research led by MIT Sloan Prof. David Rand studies the factors that convince people to adopt products and behaviors that are individually costly but beneficial to society.
By
New study commends program as a 'big step forward,' but calls for more default risk transferred to investors.